Form 4: CareDx Executive Jeffrey Novack Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reports acquiring and disposing of common stock and restricted stock units.
Summary
- On March 21, 2025, Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported transactions involving CareDx's common stock.
- Novack acquired 23,158 shares of common stock at $0.
- Novack disposed of 127,835 shares of common stock.
- Following these transactions, Novack beneficially owns 127,835 shares of common stock.
- The acquired securities are represented by restricted stock units vesting over three years, starting April 1, 2026.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The restricted stock units vest over a three-year period contingent upon continuous employment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- Shareholders are informed about the insider trading activities of a key executive.
Key Dates
| Date | Description |
|---|---|
| 03/21/2025 | Date of transaction: acquisition and disposal of common stock. |
| 03/25/2025 | Date of signature for the Form 4 filing. |
| 04/01/2026 | First vesting date for one-third of the restricted stock units. |
Keywords
CareDx, CDNA, Form 4, Beneficial Ownership, Insider Trading, Jeffrey Adam Novack, Restricted Stock Units, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.